跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Approved
THERAPEUTIC
ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Sun Pharmaceutical Industries Limited
🇸🇬 Health Sciences Authority
Approval Date
Oct 3, 2018
Approval ID
dcc30af5a0f5b29b
Company
Sun Pharmaceutical Industries Limited
Type
Therapeutic
Approval Details
Approval Id
dcc30af5a0f5b29b
Drug Name
ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Product Name
ZOBONE CONCENTRATE FOR SOLUTION FOR INFUSION 4MG/5ML
Approval Number
SIN15562P
Approval Date
2018-10-03
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
M05BA08
Atc Item Name
zoledronic acid
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Zoledronic Acid monohydrate 4.264 mg equivalent to Zoledronic acid (anhydrous basis)
4.00mg/5ml
ZOLEDRONIC ACID MONOHYDRATE 4.264 MG EQUIVALENT TO ZOLEDRONIC ACID (ANHYDROUS BASIS)
4 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 3, 2018
Approval ID
dcc30af5a0f5b29b
Type
Therapeutic
Back to HSA Approvals
